Skip to main content

Advertisement

Log in

Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to explore medication-related decision-making by health professionals from different disciplines and specialties caring for people with advanced dementia living in long-term care facilities, focusing on dilemmas associated with starting, continuing or deprescribing medications commonly regarded as potentially inappropriate.

Methods

Four focus groups were undertaken, each on a different medication type (antibiotics, lipid-lowering agents, opioids and acetylcholinesterase inhibitors). Transcripts underwent qualitative analysis using line by line inductive coding and then a person-centred framework to highlight themes across medication types.

Results

Sixteen participants participated in focus groups. Regardless of medication type or dilemma, results suggested decision-making for residents with advanced dementia should begin with discussing goals of care and engaging with families, and be viewed as an iterative process involving regular monitoring and adjustment. Decision-making was seen as requiring a dialectical approach involving multiple perspectives, with an emphasis on establishing communication between health professionals, family and the person with dementia to better understand goals/preferences for care.

Conclusion

Inter-professional collaboration enables sharing of clinical experience/expertise, differing disciplinary perspectives and knowledge about the resident. Continuing a medication should be considered an active decision that carries as much responsibility as starting or deprescribing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Van Der Steen J, Radbruch L, Hertogh C, De Boer M, Hughes J, Larkin P et al (2014) White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med 28(3):197–209

    Article  Google Scholar 

  2. Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future

  3. Birch D, Draper J (2008) A critical literature review exploring the challenges of delivering effective palliative care to older people with dementia. J Clin Nurs 17(9):1144–1163

    Article  Google Scholar 

  4. Parsons C, Hughes C, Passmore A, Lapane K (2010) Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? Drugs Aging 27(6):435–449. https://doi.org/10.2165/11536760-000000000-00000

    Article  PubMed  Google Scholar 

  5. Parsons C, McCorry N, Murphy K, Byrne S, O’sullivan D, O’mahony D et al (2014) Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psych 29(3):281–290

    Article  Google Scholar 

  6. Shega J, Ellner L, Lau D, Maxwell T (2009) Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors. J Palliat Med 12(9):779–783

    Article  Google Scholar 

  7. Holmes H. (2009) Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 85(1)

  8. Ostini R, Hegney D, Jackson C, Tett S (2012) Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 18(1):68–72

    PubMed  Google Scholar 

  9. NHMRC Cognitive Decline Partnership Centre, University of Sydney, in collaboration with the Australian Deprescribing Network and NPS MedicineWise. Quality Use of Medicines to Optimise Ageing in Older Australians: recommendations for a national strategic action plan to reduce inappropriate polypharmacy. Sydney, NSW, Australia; 2018

  10. Paque K, Vander Stichele R, Elseviers M, Pardon K, Dilles T, Deliens L, Christiaens T (2018) Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med 33(1):37–48

    Article  Google Scholar 

  11. Flanagan J (1954) The critical incident technique. Psychol Bull 51(4):327–358

    Article  CAS  Google Scholar 

  12. Bendtsen P, Hensing G, McKenzie L, Stridsman A-K (1999) Prescribing benzodiazepines—a critical incident study of a physician dilemma. Soc Sci Med 49(4):459–467

    Article  CAS  Google Scholar 

  13. Bendtsen P, Hensing G, Ebeling C, Schedin A (1999) What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 82(1):89–96

    Article  CAS  Google Scholar 

  14. Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349–357

    Article  Google Scholar 

  15. Westbury J, Gee P, Ling T, Brown D, Franks K, Bindoff I, Bindoff A, Peterson GM (2018) RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust 208(9):398–403

    Article  Google Scholar 

  16. Brodaty H, Aerts L, Harrison F, Jessop T, Cations M, Chenoweth L, Shell A, Popovic GC, Heffernan M, Hilmer S, Sachdev PS, Draper B (2018) Antipsychotic deprescription for older adults in long-term care: the HALT study. J Am Med Dir Assoc 19(7):592–600

    Article  Google Scholar 

  17. Kemppainen J (2000) The critical incident technique and nursing care quality research. J Adv Nurs 32(5):1264–1271

    Article  CAS  Google Scholar 

  18. Nielsen J, Clemmensen T, Yssing C (2002) Getting access to what goes on in people’s heads?: reflections on the think-aloud technique. Proceedings of the second Nordic conference on Human-computer interaction :101–100 ACM

  19. Eklund JH, Holmström I, Kumlin T, Kaminsky E, Skoglund K, Höglander J et al (2019) “Same same or different?” A review of reviews of person-centered and patient-centered care. Patient Education and Counseling 102(1):3–11

  20. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C (2004) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33(6):612–617

    Article  Google Scholar 

  21. Connor S, Egan K, Kwilosz D, Larson D, Reese D (2002) Interdisciplinary approaches to assisting with end-of-life care and decision making. Am Behav Sci 46(3):340–356

    Article  Google Scholar 

  22. Kurvers R, Wolf M, Naguib M, Krause J (2015) Self-organized flexible leadership promotes collective intelligence in human groups. R Soc Open Sci 2(12):150222

    Article  Google Scholar 

  23. Gheewala P, Peterson G, Curtain C, Nishtala P, Hannan P, Castelino R (2014) Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging 31(11):825–835

    Article  Google Scholar 

  24. Davies N, Mathew R, Wilcock J, Manthorpe J, Sampson E, Lamahewa K et al (2016) A co-design process developing heuristics for practitioners providing end of life care for people with dementia. BMC palliative care 15(1):68

    Article  Google Scholar 

  25. Reeve E, Bell S, Hilmer S (2015) Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review. Curr Clin Pharmacol 10(3):168–177

    Article  Google Scholar 

  26. Turner J, Edwards S, Stanners M, Shakib S, Bell S (2016) What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open 6(3):e009781

    Article  Google Scholar 

  27. Reeve E, Low L-F, Hilmer S (2016) Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract 66(649):e552–ee60

    Article  Google Scholar 

  28. D’Agata E, Mitchell S (2008) Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 168(4):357–362

    Article  Google Scholar 

  29. McLachlan A, Bath S, Naganathan V, Hilmer S, Le Couteur D, Gibson S et al (2011) Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol 71(3):351–364

    Article  CAS  Google Scholar 

  30. Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P et al (2018) Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia. The University of Sydney, Sydney, Australia, Recommendations

    Google Scholar 

  31. Parsons C (2016) Withdrawal of antidementia drugs in older people: who, when and how? Drugs Aging 33(8):545–556

    Article  CAS  Google Scholar 

  32. Narayan S, Nishtala P (2018) Population-based study examining the utilization of preventive medicines by older people in the last year of life. Geriatr Gerontol Int 18(6):892–898

    Article  Google Scholar 

  33. Van Der Cammen T, Rajkumar C, Onder G, Sterke C, Petrovic M (2014) Drug cessation in complex older adults: time for action. Age Ageing 43(1):20–25

    Article  Google Scholar 

  34. Page A, Clifford R, Potter K, Schwartz D, Etherton-Beer C (2016) The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol 82(3):583–623

    Article  Google Scholar 

  35. Ailabouni N, Nishtala P, Mangin D, Tordoff J (2016) Challenges and enablers of deprescribing: a general practitioner perspective. PLoS One 11(4):e0151066

    Article  Google Scholar 

  36. Anderson K, Stowasser D, Freeman C, Scott I (2014) Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 4(12):e006544

    Article  Google Scholar 

  37. Nisbett R, Wilson T (1977) The halo effect: evidence for unconscious alteration of judgments. J Pers Soc Psychol 35(4):250

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all participants who participated in the focus groups as part of this study.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. DD was supported by a UTS Doctoral Scholarship.

Author information

Authors and Affiliations

Authors

Contributions

DD contributed to the development of the research questions, conducted the search, analysed the articles and drafted the manuscript. TL and MA contributed to the development of research questions and analysis of data and helped to draft the manuscript. AB and PD contributed to the analysis of data. All authors contributed to and approved the final manuscript.

Corresponding author

Correspondence to Domenica Disalvo.

Ethics declarations

Ethics approval was from the University of Technology Sydney (UTS) Human Research Ethics Committee (Approval Reference No. ETH16-0291). All participants gave written informed consent to participate.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 597 kb)

ESM 2

(PDF 506 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Disalvo, D., Luckett, T., Bennett, A. et al. Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis. Eur J Clin Pharmacol 76, 567–578 (2020). https://doi.org/10.1007/s00228-019-02820-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-019-02820-z

Keywords

Navigation